CONMED | CNMD - Le Bénéfice D'Exploitation





Le Bénéfice D'Exploitation Changement Date
3M USD 1.56B 57M 2026-09
Abbott USD 1.36B 775M 2026-09
Accuray USD 4.71M 6.86M 2024-12
AtriCure USD 9.66M 9.14M 2026-06
Baxter International USD 314M 38M 2026-09
Becton, Dickinson and Co. USD 752M 125M 2026-06
Boston Scientific USD 1.01B 232M 2026-09
CONMED USD 37.14M 739K 2026-09
Cooper Companies USD 222M 253M 2026-06
Dexcom USD 318.3M 63M 2026-06
Edwards Lifesciences USD 519.5M 4.8M 2026-06
Globus Medical USD -45.97M 209.97M 2026-06
Inogen USD -7.79M 728K 2024-09
Insulet USD 129.7M 7.7M 2026-06
Integra LifeSciences USD 42.65M 1.36M 2026-09
Intuitive Surgical USD 1.05B 69.9M 2026-09
J&J USD 6.47B 1B 2026-09
Medtronic USD 1.84B 254M 2026-06
Merit Medical Systems USD 60.4M 16.25M 2026-06
Olympus JPY 30.07B 3.2B 2026-06
Orthofix International USD 6.12M 1.91M 2025-12
ResMed USD 454.34M 51.33M 2026-06
Smith & Nephew USD 505M 65M 2026-06
Steris USD 285.8M 32.9M 2026-06
Stryker USD 1.79B 687M 2026-06
Tandem Diabetes Care USD -13.79M 3.64M 2026-06
Teleflex USD 73.07M 36.04M 2026-06
Zimmer Biomet Holdings USD 344.7M 50.4M 2026-06